Li Xiao-Xin
Zhonghua Yan Ke Za Zhi. 2005 Apr;41(4):289-91.
Retinopathy of prematurity (ROP) (previously called retrolental fibroplasia), is a proliferative retinopathy of premature and low birth weight infants related with receiving oxygen therapy. ROP is the leading cause of children blindness in the developed countries. With the improvement of health level in our country, perinatal medicine has obtained much development. With the improvement of life support systems, the survival rate of premature in our country is becoming higher and the incidence of ROP is increasing accordingly. The children blindness caused by this illness is increasing, which should obtain the ophthalmologists highly attention. In this article, we discuss the data of ROP incidence in the world; the history of ROP prevention and treatment; the development of the retina, the histopathology of ROP; the international classification of ROP and the timing limit of treatment of ROP. ROP is the leading cause of children blindness in the developed countries. ROP incidence is related with the NICU's treatment and the application of relevant medical laws.
早产儿视网膜病变（ROP）（以前称为晶状体后纤维增生症），是一种与接受氧疗相关的早产儿和低体重儿增殖性视网膜病变。ROP是发达国家儿童失明的主要原因。随着我国健康水平的提高，围产医学取得了很大发展。随着生命支持系统的改善，我国早产儿的存活率越来越高，ROP的发病率也相应增加。这种疾病导致的儿童失明人数不断增加，应引起眼科医生的高度重视。在本文中，我们讨论了世界上ROP的发病率数据；ROP防治的历史；视网膜的发育、ROP的组织病理学；ROP的国际分类以及ROP治疗的时间限制。ROP是发达国家儿童失明的主要原因。ROP发病率与新生儿重症监护病房（NICU）的治疗及相关医疗法律的应用有关。
